{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:10:31Z","timestamp":1791090631376,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/sj.bjc.6605019","type":"journal-article","created":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T18:50:40Z","timestamp":1240944640000},"page":"1406-1414","source":"Crossref","is-referenced-by-count":108,"title":["Potential therapeutic targets for chordoma: PI3K\/AKT\/TSC1\/TSC2\/mTOR pathway"],"prefix":"10.1038","volume":"100","author":[{"given":"N","family":"Presneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Gikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Gout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Diss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tirabosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"BF6605019_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1158\/0008-5472.CAN-3554-2","volume":"64","author":"A Boulay","year":"2004","unstructured":"Boulay A, Zumstein-Mecker S, Stephan C, Beuvink I, Zilbermann F, Haller R, Tobler S, Heusser C, O\u2019Reilly T, Stolz B, Marti A, Thomas G, Lane HA (2004) Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells. Cancer Res 64: 252\u2013261","journal-title":"Cancer Res"},{"key":"BF6605019_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/CCO.0b013e3281214448","volume":"19","author":"PG Casali","year":"2007","unstructured":"Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A (2007) Chordoma. Curr Opin Oncol 19: 367\u2013370","journal-title":"Curr Opin Oncol"},{"key":"BF6605019_CR3","doi-asserted-by":"publisher","first-page":"15719","DOI":"10.1074\/jbc.C300534200","volume":"279","author":"SW Cheng","year":"2004","unstructured":"Cheng SW, Fryer LG, Carling D, Shepherd PR (2004) Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem 279: 15719\u201315722","journal-title":"J Biol Chem"},{"key":"BF6605019_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/humu.20874","volume":"30","author":"R Cmejla","year":"2009","unstructured":"Cmejla R, Cmejlova J, Handrkova H, Petrak J, Petrtylova K, Mihal V, Stary J, Cerna Z, Jabali Y, Pospisilova D (2009) Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond\u2013Blackfan anemia. Hum Mutat 30: 321\u2013327","journal-title":"Hum Mutat"},{"key":"BF6605019_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.semcdb.2004.01.002","volume":"15","author":"J Downward","year":"2004","unstructured":"Downward J (2004) PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15: 177\u2013182","journal-title":"Semin Cell Dev Biol"},{"key":"BF6605019_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/5951","volume":"21","author":"N Draptchinskaia","year":"1999","unstructured":"Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I, Ball S, Tchernia G, Klar J, Matsson H, Tentler D, Mohandas N, Carlsson B, Dahl N (1999) The gene encoding ribosomal protein S19 is mutated in Diamond\u2013Blackfan anaemia. Nat Genet 21: 169\u2013175","journal-title":"Nat Genet"},{"key":"BF6605019_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/labinvest.3700494","volume":"87","author":"M El-Salem","year":"2007","unstructured":"El-Salem M, Raghunath PN, Marzec M, Wlodarski P, Tsai D, Hsi E, Wasik MA (2007) Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders. Lab Invest 87: 29\u201339","journal-title":"Lab Invest"},{"key":"BF6605019_CR8","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","volume":"7","author":"ME Feldman","year":"2009","unstructured":"Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, Ruggero D, Shokat KM (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 7: e38","journal-title":"PLoS Biol"},{"key":"BF6605019_CR9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.bbrc.2003.09.132","volume":"310","author":"N Gao","year":"2003","unstructured":"Gao N, Zhang Z, Jiang BH, Shi X (2003) Role of PI3K\/AKT\/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 310: 1124\u20131132","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6605019_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1158\/0008-5472.CAN-07-5635","volume":"68","author":"JR Graff","year":"2008","unstructured":"Graff JR, Konicek BW, Carter JH, Marcusson EG (2008) Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 68: 631\u2013634","journal-title":"Cancer Res"},{"key":"BF6605019_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/sj.bjc.6604130","volume":"98","author":"KH Hallor","year":"2008","unstructured":"Hallor KH, Staaf J, Jonsson G, Heidenblad M, Vult von SF, Bauer HC, Ijszenga M, Hogendoorn PC, Mandahl N, Szuhai K, Mertens F (2008) Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 98: 434\u2013442","journal-title":"Br J Cancer"},{"key":"BF6605019_CR12","doi-asserted-by":"publisher","first-page":"9666","DOI":"10.1073\/pnas.171301998","volume":"98","author":"H Harada","year":"2001","unstructured":"Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ (2001) p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 98: 9666\u20139670","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6605019_CR13","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/gb-2005-6-9-r76","volume":"6","author":"SR Henderson","year":"2005","unstructured":"Henderson SR, Guiliano D, Presneau N, McLean S, Frow R, Vujovic S, Anderson J, Sebire N, Whelan J, Athanasou N, Flanagan AM, Boshoff C (2005) A molecular map of mesenchymal tumors. Genome Biol 6: R76","journal-title":"Genome Biol"},{"key":"BF6605019_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648\u2013657","journal-title":"Nat Cell Biol"},{"key":"BF6605019_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1083\/jcb.jcb.200206108","volume":"159","author":"A Jaeschke","year":"2002","unstructured":"Jaeschke A, Hartkamp J, Saitoh M, Roworth W, Nobukuni T, Hodges A, Sampson J, Thomas G, Lamb R (2002) Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J Cell Biol 159: 217\u2013224","journal-title":"J Cell Biol"},{"key":"BF6605019_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"DH Kim","year":"2002","unstructured":"Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163\u2013175","journal-title":"Cell"},{"key":"BF6605019_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10585-006-9033-y","volume":"23","author":"K Krishnan","year":"2006","unstructured":"Krishnan K, Bruce B, Hewitt S, Thomas D, Khanna C, Helman LJ (2006) Ezrin mediates growth and survival in Ewing's sarcoma through the AKT\/mTOR, but not the MAPK, signaling pathway. Clin Exp Metastasis 23: 227\u2013236","journal-title":"Clin Exp Metastasis"},{"key":"BF6605019_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/gcc.20052","volume":"41","author":"L Lee-Jones","year":"2004","unstructured":"Lee-Jones L, Aligianis I, Davies PA, Puga A, Farndon PA, Stemmer-Rachamimov A, Ramesh V, Sampson JR (2004) Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2. Genes Chromosomes Cancer 41: 80\u201385","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6605019_CR19","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1128\/MCB.24.18.7965-7975.2004","volume":"24","author":"Y Li","year":"2004","unstructured":"Li Y, Inoki K, Guan KL (2004) Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol Cell Biol 24: 7965\u20137975","journal-title":"Mol Cell Biol"},{"key":"BF6605019_CR20","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1158\/1078-0432.CCR-07-0321","volume":"14","author":"KH Lu","year":"2008","unstructured":"Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR, Walker CL (2008) Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res 14: 2543\u20132550","journal-title":"Clin Cancer Res"},{"key":"BF6605019_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1586\/14737140.7.8.1145","volume":"7","author":"AR MacKenzie","year":"2007","unstructured":"MacKenzie AR, von Mehren M (2007) Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future. Expert Rev Anticancer Ther 7: 1145\u20131154","journal-title":"Expert Rev Anticancer Ther"},{"key":"BF6605019_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ceb.2005.02.008","volume":"17","author":"DE Martin","year":"2005","unstructured":"Martin DE, Hall MN (2005) The expanding TOR signaling network. Curr Opin Cell Biol 17: 158\u2013166","journal-title":"Curr Opin Cell Biol"},{"key":"BF6605019_CR23","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.ijrobp.2006.02.059","volume":"65","author":"L Park","year":"2006","unstructured":"Park L, Delaney TF, Liebsch NJ, Hornicek FJ, Goldberg S, Mankin H, Rosenberg AE, Rosenthal DI, Suit HD (2006) Sacral chordomas: impact of high-dose proton\/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 65: 1514\u20131521","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6605019_CR24","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/sj.emboj.7600193","volume":"23","author":"B Raught","year":"2004","unstructured":"Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, Polakiewicz RD, Sonenberg N, Hershey JW (2004) Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23: 1761\u20131769","journal-title":"EMBO J"},{"key":"BF6605019_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cub.2004.08.061","volume":"14","author":"CJ Richardson","year":"2004","unstructured":"Richardson CJ, Broenstrup M, Fingar DC, Julich K, Ballif BA, Gygi S, Blenis J (2004) SKAR is a specific target of S6 kinase 1 in cell growth control. Curr Biol 14: 1540\u20131549","journal-title":"Curr Biol"},{"key":"BF6605019_CR26","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1158\/0008-5472.CAN-06-0364","volume":"66","author":"MJ Riemenschneider","year":"2006","unstructured":"Riemenschneider MJ, Betensky RA, Pasedag SM, Louis DN (2006) AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling. Cancer Res 66: 5618\u20135623","journal-title":"Cancer Res"},{"key":"BF6605019_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/path.1987","volume":"209","author":"S Romeo","year":"2006","unstructured":"Romeo S, Hogendoorn PC (2006) Brachyury and chordoma: the chondroid\u2013chordoid dilemma resolved? J Pathol 209: 143\u2013146","journal-title":"J Pathol"},{"key":"BF6605019_CR28","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1073\/pnas.0405659101","volume":"101","author":"PP Roux","year":"2004","unstructured":"Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 101: 13489\u201313494","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6605019_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/01.cco.0000143964.74936.d1","volume":"16","author":"EK Rowinsky","year":"2004","unstructured":"Rowinsky EK (2004) Targeting the molecular target of rapamycin (mTOR). Curr Opin Oncol 16: 564\u2013575","journal-title":"Curr Opin Oncol"},{"key":"BF6605019_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/cncr.22001","volume":"107","author":"LB Rozeman","year":"2006","unstructured":"Rozeman LB, Szuhai K, Schrage YM, Rosenberg C, Tanke HJ, Taminiau AH, Cleton-Jansen AM, Bovee JV, Hogendoorn PC (2006) Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations. Cancer 107: 380\u2013388","journal-title":"Cancer"},{"key":"BF6605019_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tibs.2006.04.003","volume":"31","author":"I Ruvinsky","year":"2006","unstructured":"Ruvinsky I, Meyuhas O (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31: 342\u2013348","journal-title":"Trends Biochem Sci"},{"key":"BF6605019_CR32","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1101\/gad.351605","volume":"19","author":"I Ruvinsky","year":"2005","unstructured":"Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T, Dor Y, Zisman P, Meyuhas O (2005) Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev 19: 2199\u20132211","journal-title":"Genes Dev"},{"key":"BF6605019_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554","journal-title":"Science"},{"key":"BF6605019_CR34","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296\u20131302","journal-title":"Curr Biol"},{"key":"BF6605019_CR35","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt\/PKB by the rictor\u2013mTOR complex. Science 307: 1098\u20131101","journal-title":"Science"},{"key":"BF6605019_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/gcc.1184","volume":"32","author":"S Scheil","year":"2001","unstructured":"Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, Schulte M, Moller P (2001) Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32: 203\u2013211","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6605019_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1601-0825.2007.01421.x","volume":"14","author":"MA Scheper","year":"2008","unstructured":"Scheper MA, Chaisuparat R, Nikitakis NG, Sauk JJ (2008) Expression and alterations of the PTEN\/AKT\/mTOR pathway in ameloblastomas. Oral Dis 14: 561\u2013568","journal-title":"Oral Dis"},{"key":"BF6605019_CR38","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1016\/j.febslet.2005.07.054","volume":"579","author":"AR Tee","year":"2005","unstructured":"Tee AR, Blenis J, Proud CG (2005) Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett 579: 4763\u20134768","journal-title":"FEBS Lett"},{"key":"BF6605019_CR39","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/PAS.0b013e31815b693a","volume":"32","author":"R Tirabosco","year":"2008","unstructured":"Tirabosco R, Mangham DC, Rosenberg AE, Vujovic S, Bousdras K, Pizzolitto S, De MG, den Bakker MA, Di FL, Kalil RK, Athanasou NA, O\u2019donnell P, McCarthy EF, Flanagan AM (2008) Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor\/myoepithelioma\/parachordoma in soft tissue. Am J Surg Pathol 32: 572\u2013580","journal-title":"Am J Surg Pathol"},{"key":"BF6605019_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0022-1759(02)00210-7","volume":"268","author":"C Tkaczyk","year":"2002","unstructured":"Tkaczyk C, Metcalfe DD, Gilfillan AM (2002) Determination of protein phosphorylation in Fc epsilon RI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions. J Immunol Methods 268: 239\u2013243","journal-title":"J Immunol Methods"},{"key":"BF6605019_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/path.1969","volume":"209","author":"S Vujovic","year":"2006","unstructured":"Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209: 157\u2013165","journal-title":"J Pathol"},{"key":"BF6605019_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471\u2013484","journal-title":"Cell"},{"key":"BF6605019_CR43","doi-asserted-by":"publisher","first-page":"19793","DOI":"10.1074\/jbc.C600028200","volume":"281","author":"L Yan","year":"2006","unstructured":"Yan L, Findlay GM, Jones R, Procter J, Cao Y, Lamb RF (2006) Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase. J Biol Chem 281: 19793\u201319797","journal-title":"J Biol Chem"},{"key":"BF6605019_CR44","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1101\/gad.1461206","volume":"20","author":"Q Yang","year":"2006","unstructured":"Yang Q, Inoki K, Ikenoue T, Guan KL (2006a) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev 20: 2820\u20132832","journal-title":"Genes Dev"},{"key":"BF6605019_CR45","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1073\/pnas.0602282103","volume":"103","author":"Q Yang","year":"2006","unstructured":"Yang Q, Inoki K, Kim E, Guan KL (2006b) TSC1\/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc Natl Acad Sci USA 103: 6811\u20136816","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605019","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:39:18Z","timestamp":1684399158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BF6605019"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605019","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]}}}